Company Overview
Development of strategies on commercial sales of PeriCoach, intellectual property of medical device and mobile health application in relation in relation to patents and systems in the pelvic floor exercise field (PeriCoach), in relation to patents in the burette field (AutoStart/Flush Enhanced Infusion System), and strategies for commercial sales of burette products.
Website | www.analyticamedical.com |
---|---|
Head Office | Brisbane QLD |
Registry | Link Market Services |
CEO | Geoff Daly |
Chair Person | Michael Monsour |
GICS Industry | Health Care Equipment & Services |
Sub Industry | Health Care Equipment |
Sector | Health Care |
Market Cap | $5 m |
---|---|
Shares on Issue | 4,613 b |
Status | Suspended |
Last Price | |
Change | |
52 Week H/L | |
VWAP | |
Bid/Ask |
Directors and Management
Dr Michael Monsour
Non-Executive Chairman,Non-Executive Director 28/06/2004
Dr Monsour is a Medical Practitioner with extensive interests in Queensland medical and dental centres. He operates a medical management company, which provides management support to medical and dental practitioners. He is the principal of Godbar Software (established 1988).
MBBS-HONS, FACRRM, FAICD Medical Practitioner Male
Mr Ross Mangelsdorf
Executive Director 30/09/2010
Mr Mangelsdorf is a Director/partner of a chartered accounting firm for 38 years. He works with SME production, manufacturing and retail firms assisting with business, taxation and management services.
B.Bus, FCA, FTIA, MAICD Male
Dr Peter B Corr
Non-Executive Director 22/05/2017
Dr. Corr has experience in the discovery and development of medicines as well as the sale of assets to major multinational corporations. Dr. Corr co-founded and is Managing General Partner of Auven Therapeutics, developed and then sold to multinational pharmaceutical firms. Dr. Corr was previously a Professor of Medicine and Pharmacology at Washington University for 18 years. He then joined Searle as Senior VP of Discovery Research, and subsequently was President of Research and Development at Warner Lambert / Parke Davis and then President, worldwide Development at Pfizer, and Corporate Senior Vice President of Science and Technology at Pfizer. Dr Corr is currently executive chairman of InVax Inc.
Doctorate Male
Top 20 Shareholders
Name | Shares | % | |
---|---|---|---|
1. | Halonna Pty Ltd | 422,448,640 | 0.00 |
2. | Inov8 Llc | 360,790,157 | 0.00 |
3. | Mpamm Pty Ltd | 233,042,390 | 0.00 |
4. | M P Monsour Medical Practice Pty Ltd | 156,379,178 | 0.00 |
5. | Ignatius Lip Pty Ltd | 151,073,534 | 0.00 |
6. | Dr T M Mullins + Dr P J Mullins | 102,776,626 | 0.00 |
7. | Mr M Arundel + Mrs S Arundel | 75,000,000 | 0.00 |
8. | Van Am Marketing Pty Ltd | 68,375,148 | 0.00 |
9. | Halonna Pty Ltd I | 60,156,250 | 0.00 |
10. | Mr R T M Daly + Mrs S K Daly | 55,936,240 | 0.00 |
11. | Tambien Pty Ltd | 51,633,561 | 0.00 |
12. | Fitzwill Superannuation Pty Ltd | 50,000,000 | 0.00 |
13. | Cmonsuper Pty Ltd | 49,632,352 | 0.00 |
14. | W Brooks Investments Pty Ltd | 48,645,000 | 0.00 |
15. | Neatford Pty Ltd | 40,009,545 | 0.00 |
16. | Bnp Paribas Nominees Pty Ltd | 34,952,711 | 0.00 |
17. | Dalrose Pty Ltd | 30,000,001 | 0.00 |
18. | Mrs Sabina Lip | 29,600,000 | 0.00 |
19. | Mrs Marge Mei Yu Lip | 29,370,586 | 0.00 |
20. | Mr M Arundel + Mrs S Arundel I | 29,000,000 | 0.00 |
Director Transactions
Date | Name | Qty | Value | Direction | Notes |
---|---|---|---|---|---|
18/06/2021 | Michael Monsour | 214,285,714 | $750,000 | Issued | Placement. As per announcement on 22/06/2021. |
18/06/2021 | Michael Monsour | 214,285,714 | $750,000 | Issued | Placement. |
18/06/2021 | Ross Mangelsdorf | 50,000,000 | $150,000 | Issued | Issue of securities. |